This study compared the effects of low and high doses of botulinum toxin A (BTX‐A) to
improve upper extremity function. Thirty‐nine children (22 males, 17 females) with a mean …

This study evaluated the improvement in clinical measures and quality of life (QOL) among
patients with cerebral palsy treated with botulinum toxin type A. Fifty-seven parents of …

Aim The aim of this study was to determine the effects of repeat botulinum toxin A (Bo NT‐A)
injections in children with spastic cerebral palsy (CP) on the basis of a best evidence …

Over the past 5 years a number of studies of the use of Botulinum toxin A in the management
of cerebral palsy have been conducted. Overall 105 children, with a mean age of 6 years …

The use of botulinum toxin was studied in 17 children with spastic cerebral palsy to
determine its efficacy and tolerability. Eleven ambulatory and 6 nonambulatory patients were …

Background Spasticity is a common motor disorder in children with cerebral palsy (CP).
Upper limb CP impairment has a significant negative impact on daily activities. Botulinum …

INTRODUCTION: The aim of this study is to review the literature to indications of botulinum
toxin type A in children. METHOD: We review the international literature from 1990 to 2002 …

Therapeutic effect of botulinum toxin A was studied in a group of pediatric patients (n= 28)
aged between 6 months and 18 years. The patients were diagnosed with cervical dystonia …

The treatment of children with cerebral palsy with Botulinum Toxin is considered safe and
effective, but is only approved for children older than two years of age. The effect of BoNT-A …

The author comments on a study which investigated the clinical role of botulinum toxin A
(BoNT-A) injection, by Alhusaini and colleagues, published within the issue. He provides an …